REGENXBIO Inc is a biotechnology business based in the US. REGENXBIO shares (RGNX) are listed on the NASDAQ and all prices are listed in US Dollars. REGENXBIO employs 306 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in REGENXBIO
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RGNX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
REGENXBIO stock price (NASDAQ: RGNX)Use our graph to track the performance of RGNX stocks over time.
REGENXBIO shares at a glance
|Latest market close||$35.27|
|52-week range||$25.93 - $50.26|
|50-day moving average||$37.68|
|200-day moving average||$38.96|
|Wall St. target price||$64.38|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.36|
Buy REGENXBIO shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy REGENXBIO stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
REGENXBIO price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-9.52%|
|3 months (2021-04-28)||-1.48%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is REGENXBIO under- or over-valued?
Valuing REGENXBIO stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of REGENXBIO's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
REGENXBIO's PEG ratio
REGENXBIO's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.26. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into REGENXBIO's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$155.8 million|
|Gross profit TTM||$-47,441,000|
|Return on assets TTM||-11.69%|
|Return on equity TTM||-24.9%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
Shorting REGENXBIO shares
There are currently 3.3 million REGENXBIO shares held short by investors – that's known as REGENXBIO's "short interest". This figure is 11.3% down from 3.7 million last month.
There are a few different ways that this level of interest in shorting REGENXBIO shares can be evaluated.
REGENXBIO's "short interest ratio" (SIR)
REGENXBIO's "short interest ratio" (SIR) is the quantity of REGENXBIO shares currently shorted divided by the average quantity of REGENXBIO shares traded daily (recently around 350601.49253731). REGENXBIO's SIR currently stands at 9.38. In other words for every 100,000 REGENXBIO shares traded daily on the market, roughly 9380 shares are currently held short.
However REGENXBIO's short interest can also be evaluated against the total number of REGENXBIO shares, or, against the total number of tradable REGENXBIO shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case REGENXBIO's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 REGENXBIO shares in existence, roughly 80 shares are currently held short) or 0.095% of the tradable shares (for every 100,000 tradable REGENXBIO shares, roughly 95 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against REGENXBIO.
Find out more about how you can short REGENXBIO stock.
REGENXBIO share dividends
We're not expecting REGENXBIO to pay a dividend over the next 12 months.
REGENXBIO share price volatility
Over the last 12 months, REGENXBIO's shares have ranged in value from as little as $25.925 up to $50.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while REGENXBIO's is 1.1687. This would suggest that REGENXBIO's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
REGENXBIO Inc. , a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II; RGX-111, which is in Phase I clinical trial for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease; and RGX-501, which is in Phase I/II clinical trials to treat homozygous familial hypercholesterolemia. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop vectorized antibodies for the treatment of neurodegenerative diseases.
Stocks similar to REGENXBIO
REGENXBIO in the news
Where Do Hedge Funds Stand On Regenxbio Inc (RGNX)?
Abeona Therapeutics: Tribunal finds in favor of Regenxbio in arbitration claims
Piper Sandler biotech analysts hold an analyst/industry conference call
Frequently asked questionsWhat percentage of REGENXBIO is owned by insiders or institutions?
Currently 12.519% of REGENXBIO shares are held by insiders and 84.9% by institutions. How many people work for REGENXBIO?
Latest data suggests 306 work at REGENXBIO. When does the fiscal year end for REGENXBIO?
REGENXBIO's fiscal year ends in December. Where is REGENXBIO based?
REGENXBIO's address is: 9600 Blackwell Road, Rockville, MD, United States, 20850 What is REGENXBIO's ISIN number?
REGENXBIO's international securities identification number is: US75901B1070 What is REGENXBIO's CUSIP number?
REGENXBIO's Committee on Uniform Securities Identification Procedures number is: 75901B107
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert